Osaic Holdings
QNCX icon

Osaic Holdings’s Quince Therapeutics QNCX Stock Holding History

Osaic Holdings’s Portfolio QNCX Stock Details QNCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3
Closed -$55 – 8143
2026
Q1 		$55 Sell
3
-1
-25% -$201 ﹤0.01% 7676
2025
Q4 		$2.77K Hold
4
– – ﹤0.01% 6970
2025
Q3 		$1.32K Buy
4
+3
+300% +$999 ﹤0.01% 7262
2025
Q2 		$457 Hold
1
– – ﹤0.01% 7367
2025
Q1 		$368 Sell
1
-3
-75% -$916 ﹤0.01% 7061
2024
Q4 		$1.46K Buy
4
+3
+300% +$901 ﹤0.01% 6726
2024
Q3 		$216 Hold
1
– – ﹤0.01% 7163
2024
Q2 		$207 Hold
1
– – ﹤0.01% 7164
2024
Q1 		$293 Hold
1
– – ﹤0.01% 6907
2023
Q4 		$290 Hold
1
– – ﹤0.01% 6973
2023
Q3 		$310 Hold
1
– – ﹤0.01% 7074
2023
Q2 		$416 Hold
1
– – ﹤0.01% 7091
2023
Q1 		$432 Hold
1
– – ﹤0.01% 7158
2022
Q4 		$0 Hold
1
– – ﹤0.01% 7385
2022
Q3 		$0 Hold
1
– – ﹤0.01% 7458
2022
Q2 		$1K Buy
+1
New +$707 ﹤0.01% 7135
2022
Q1 		– Hold
0
– -$1K – 7441
2021
Q4 		– Sell
-3
Closed -$18.3K – 7230
2021
Q3 		$53K Sell
3
-2
-40% -$31.8K ﹤0.01% 5058
2021
Q2 		$58K Buy
5
+2
+67% +$16.8K ﹤0.01% 4935
2021
Q1 		$18K Buy
+3
New +$21.6K ﹤0.01% 5562
2020
Q2 		– Hold
0
– -$1K – 6282
2020
Q1 		– Hold
0
– – – 5899

Other funds holding QNCX

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Osaic Holdings's QNCX Position: Q2 2026 in Review

Osaic Holdings sold out of Quince Therapeutics (QNCX) in Q2 2026, closing a stake of 3 shares — an estimated $55 sold.

Osaic Holdings first reported a position in QNCX in Q1 2021 and held it in 19 quarters. The position peaked at $58K in Q2 2021. 27 funds tracked by Wall St. Rank hold QNCX as of Q2 2026.

  • Osaic Holdings reported no remaining Quince Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Osaic Holdings sold 3 Quince Therapeutics shares in Q2 2026, an estimated $55.
  • Osaic Holdings first reported a position in Quince Therapeutics in Q1 2021 and held it in 19 quarters.
  • Osaic Holdings's Quince Therapeutics position peaked at $58K in Q2 2021.
  • 27 funds tracked by Wall St. Rank held Quince Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.